Navigation Links
Salix Pharmaceuticals Previews Digestive Disease Week 2007

f C. difficile strain Z. Jiang, M.D. May 20 isolated from patients with hospital- associated diarrhea The effect of selective intestinal A. Saveriadis, M.D. May 20 decontamination on liver hemodynamics in patients with alcohol related decompensated cirrhosis Restless leg syndrome in patients with L. Weinstock, M.D. May 21 irritable bowel disease: response to bacterial overgrowth therapy Small intestinal bacterial overgrowth in L. Weinstock, M.D. May 21 patients with interstitial cystitis and gastrointestinal symptoms Double blind, randomized study to M. Lukas, M.D. May 22 evaluate efficacy and urinary excretional rate of two doses of rifaximin-EIR in mild to moderate active Crohn's disease (GRACE 02 study) Rifaximin as a steroid-sparing T. Shah, M.D. May 23 medication in the management of patients with mild to moderate inflammatory bowel disease Decreasing rates of colectomy despite M. Issa, M.D. May 23 high rates of hospitalization in C. difficile infected IBD patients: a tertiary referral center experience MOVIPREP Better efficacy of a new 2-liter bowel L. Clark May 22 cleansing preparation in the ascending colon Randomised and controlled clinical trial H. Gruss May 23 of polyethylene glycol with electrolytes and ascorbic acid in comparison to sodium phosphate for bowel preparation before colon cancer screening colonoscopy COLAZAL Efficacy and safety of balsalazide for J. Quiros May 22 treatment of pediatric patients with mild to moderate ulcerative colitis: A randomized double-blind study

CONTINUING MEDICAL EDUCATION ACTIVITES

In addition, Salix is supporting, through an unrestricted educational grant, two continuing medical education activities in conjunction with DDW this year: -0-

"Navigating the
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Salix Pharmaceuticals Previews Digestive Disease Week
(Date:5/27/2015)... -- The prevalence of cardiovascular disease in ... and changes in consumption concept, dietary habit, way of ... year, thereby promoting the development of domestic percutaneous coronary ... totaled 454,505 in 2013, up 16.9% from ... there was worth RMB20.12 billion. At present, half ...
(Date:5/27/2015)... 2015 Research and Markets ( ... "North America Portable X Ray Devices Market - ... to their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... market for Portable X-Ray Devices is expected ... to 2020 X-Ray is a form ...
(Date:5/27/2015)... WORTH, Texas , May 27, 2015 ... defines and segments the concerned market with analysis and ... $1,017.8 million by 2019 and is estimated to grow ... 2019. Browse through the TOC of the ... idea of the in-depth analysis provided. This report also ...
Breaking Medicine Technology:China Interventional Cardiovascular Device Industry Report, 2014-2017 2China Interventional Cardiovascular Device Industry Report, 2014-2017 3North America Portable X Ray Devices Market Report 2015 - Growth, Trends And Forecasts 2014-2019 2Vitreoretinal Surgery Devices Market is Expected to Reach $1,017.8 Million by 2019, at a CAGR of 8.9 % From 2014 to 2019 2Vitreoretinal Surgery Devices Market is Expected to Reach $1,017.8 Million by 2019, at a CAGR of 8.9 % From 2014 to 2019 3
... Corporation (Nasdaq: DNDN ) announced today that ... remainder of its New Jersey manufacturing facility, allowing the ... to help meet the needs of patients with asymptomatic ... cancer.   Last April, upon receiving FDA ...
... Hospital and SynCardia Systems, Inc. announced today that Texas ... complete the first phase of certification to implant the ... use the Total Artificial Heart as a bridge to ... as children and now require mechanical support as a ...
Cached Medicine Technology:Dendreon Expands Launch of PROVENGE 2Dendreon Expands Launch of PROVENGE 3Dendreon Expands Launch of PROVENGE 4Dendreon Expands Launch of PROVENGE 5Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 2Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 3
(Date:5/27/2015)... CA (PRWEB) May 27, 2015 Under ... director, Bree Nasti, the Adelphi University softball team made ... Divsion II Softball Championship since becoming a Division II ... Adelphi University softball team turned it around enough to ... After defeating University of Central Missouri in the first ...
(Date:5/27/2015)... San Diego, CA (PRWEB) May 27, 2015 ... sharing and teleradiology services, is pleased to introduce Mr. ... Mr. Hafey has a proven track record of ... the healthcare information technology domain. He most recently served ... and previously held the role of Chief Architect for ...
(Date:5/27/2015)... Down is a reputable source of 2015 NHL Western Conference ... middle of their series against the Anaheim Ducks with the Ducks ... can win tonight at home, this will tie up the series ... Honda Center in Anaheim. , During the regular season, the ... they won the Pacific Division by 8 points ahead of the ...
(Date:5/27/2015)... Western University of Health Sciences’ 34th Annual ... -- and one profound last. , The May 20-22, ... first time the university surpassed more than 1,000 graduates ... of Biomedical Sciences (GCBS) alumnus graduated from the College ... university’s fifth and final ceremony of its three-day Commencement ...
(Date:5/27/2015)... As the U.S. Supreme Court considers the legality ... Affordable Care Act (ACA), an investigation by the University ... Corporation and Express Scripts provides an unprecedented look at ... , The analysis is published online as a ... appear in the journal’s June issue. , The study ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Softball Camps Congratulate the Adelphi University Softball Team 2Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4
... Feb. 24 Walter Reed Army Medical Center treated its ... (TMS) Therapy device. Walter Reed is the first DoD ... U.S. facilities so far - joining others such as ... with the equipment and capability. A TMS Therapy device was ...
... Feb. 24 An Egyptian doctor, Mahmoud Fathalla, ... Nicaraguense (MCN), have won this year,s United ... individuals and institutions for outstanding work in population ... Award Committee, chaired by Malaysia,s Ambassador to the ...
... engagement makes the difference.ALLENTOWN, Pa., Feb. 24 ... most companies in America covet: reduced usage of ... disease and use of wellness programs by employees. ... the power of the physician-patient relationship in a ...
... for black and white men, researchers say , , TUESDAY, Feb. ... to help determine the likelihood of a man developing prostate ... as well as in whites, a new study shows. , ... Cancer Prevention Research . , High levels of prostate-specific ...
... -- The evidence shows more clearly than ever that ... well-being, and safety-net services are not enough to prevent ... a new report from the Institute of Medicine. Moreover, ... are relatively high, even people with insurance are more ...
... LUNG ASSOCIATION OF MICHIGAN URGES DETROIT EMPLOYERS TO SEE ... Influenza results in billions of dollars in lost wages ... 75 million missed workdays a year, and about 200 ... vaccine-preventable disease. Yet vaccination rates remain alarmingly low, especially ...
Cached Medicine News:Health News:Walter Reed First Military Hospital to Use Transcranial Magnetic Stimulation to Treat Depression 2Health News:Egyptian Doctor, Nicaraguan NGO Win 2009 UN Population Award 2Health News:Egyptian Doctor, Nicaraguan NGO Win 2009 UN Population Award 3Health News:Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes 2Health News:Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes 3Health News:Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes 4Health News:Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes 5Health News:PSA Tests Not Race-Specific, Study Finds 2Health News:Health insurance essential for health and well-being 2Health News:Health insurance essential for health and well-being 3Health News:Influenza Infection Costs Employees Billions Each Year; Working Adults Largest Group Not Immunized Annually 2Health News:Influenza Infection Costs Employees Billions Each Year; Working Adults Largest Group Not Immunized Annually 3Health News:Influenza Infection Costs Employees Billions Each Year; Working Adults Largest Group Not Immunized Annually 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: